Seiji Isonishi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Prognostic significance of Ki67 during neoadjuvant chemotherapy in primary unresectable ovarian cancer.
Journal: The journal of obstetrics and gynaecology research
Published: March 09, 2021
Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin.
Journal: In vivo (Athens, Greece)
Published: July 10, 2019
Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 11, 2018
The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1).
Journal: Gynecologic oncology
Published: October 22, 2018
Clinical associations of Trousseau's syndrome associated with cerebral infarction and ovarian cancer.
Journal: Journal of gynecologic oncology
Published: February 18, 2018
Usefulness of ascites cytology for the evaluation of chemotherapy response in ovarian carcinosarcoma.
Journal: Cytopathology : official journal of the British Society for Clinical Cytology
Published: November 28, 2017
Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer.
Journal: Journal of gynecologic oncology
Published: August 04, 2017
Stepwise increase of MIB-1 index in frequently relapsed malignant peritoneal mesothelioma.
Journal: International cancer conference journal
Published: November 20, 2016
Concurrent high-grade serous carcinoma and borderline tumor demonstrating different chemo-sensitivity.
Journal: International cancer conference journal
Published: September 12, 2016
Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 13, 2016
Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Journal: Japanese journal of clinical oncology
Published: July 11, 2016
Last Updated: 09/26/2026